Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

SCAI celebrates new federal funding for PAD prevention

PAD CLI screening truck at ACC.24. The vehicle is sponsored by Johnson & Johnson.

The group's hope is that these new funds will help address the rising rates of PAD and CLTI throughout the United States.

  • Read more about SCAI celebrates new federal funding for PAD prevention

FDA confirms more recalls for Johnson & Johnson heart pumps due to malfunction risk

FDA recall medical device recall product recall

The issue, first announced to the public in February, has been linked to 22 serious injuries. Customers are urged to review the updated instructions for use to avoid any potential complications. 

  • Read more about FDA confirms more recalls for Johnson & Johnson heart pumps due to malfunction risk

Johnson & Johnson launches 3 new stroke devices

Cereglide 57 image courtesy of Johnson & Johnson MedTech.

Cereglide 57 image courtesy of Johnson & Johnson MedTech.

These devices were developed to help clinicians reach and remove distal clots associated with significant pain and swelling. If left untreated, such clots can lead to medical emergencies and even death.

  • Read more about Johnson & Johnson launches 3 new stroke devices

FDA approves next-generation CardioMEMS reader for heart failure monitoring

Abbott has secured U.S. Food and Drug Administration (FDA) approval for its CardioMEMS HERO device, a next-generation pulmonary artery (PA) pressure reader for heart failure patients.

The updated reader is 60% smaller and offers built-in WiFi connectivity. It works with an implantable sensor to monitor a patient's PA pressure. 

  • Read more about FDA approves next-generation CardioMEMS reader for heart failure monitoring

GLP-1 drugs and healthy habits work together to boost heart health, Harvard study confirms

Semaglutide (Wegovy) injector pen. Photo by Dave Fornell

When patients on GLP-1 therapy also make healthy lifestyle choices—getting enough sleep and exercising, for example—the benefits are significantly greater. 

  • Read more about GLP-1 drugs and healthy habits work together to boost heart health, Harvard study confirms

AI helps identify risk in adults with congenital heart disease

 3D printed congenital single ventricle patient from a CT scan, displayed at RSNA 2023 by Medviso. Models like this can help in surgical preplanning and peri-procedural guidance.#RSNA #RSNA23 #RSNA2024 #SCAI

A 3D printed model to help preplan and guide congenital heart surgery in a pediatric patient with a single ventricle. Photo by Dave Fornell

STS plans on using new research out of Mayo Clinic to help with the development of a surgical risk calculator for adults with this challenging condition.

  • Read more about AI helps identify risk in adults with congenital heart disease

New heart device for ‘no-option’ chest pain patients shows early potential

Image of the A-FLUX Reducer System for chest pain by VahatiCor.

The self-expanding, recapturable coronary sinus reducer was associated with a safe implant procedure and "promising" outcomes after six months. Additional research is already underway.

  • Read more about New heart device for ‘no-option’ chest pain patients shows early potential

Radiation doses during heart scans vary dramatically from one country to the next

A patient being set up for a cardiac CCTA scan at Duly Healthcare in the Chicago suburbs. Photo by Dave Fornell

A patient being set up for a CCTA scan at Duly Healthcare in the Chicago suburbs. Photo by Dave Fornell

Newer imaging technologies designed to use less radiation have made a considerable impact. In parts of the world where those systems have not yet been implemented, however, radiation dose levels remain quite high. 

  • Read more about Radiation doses during heart scans vary dramatically from one country to the next

Whole-body MRI provider starts offering AI-powered CCTA scans

Performing CT-derived fractional flow reserve (CT-FFR) before transcatheter aortic valve replacement (TAVR) improves the accuracy of coronary CT angiography (CCTA) and helps limit unneeded invasive coronary angiography (ICA), according to a new study published in JACC: Cardiovascular Interventions. Heartflow

Image courtesy of Heartflow.

Patients electing to undergo a whole-body MRI at one Florida facility are now able to undergo a CCTA exam at the same time. All results are interpreted by a cardiologist, and the patient meets with a physician for a one-on-one consultation.  

  • Read more about Whole-body MRI provider starts offering AI-powered CCTA scans

Vascular imaging at heart of $71M fraud scheme—DOJ announces prison sentences

Medicare fraud

The years-long scheme involved sending kickbacks to physicians who ordered unnecessary transcranial doppler exams. Two conspirators have now been sentenced to prison and ordered to pay substantial fines.

  • Read more about Vascular imaging at heart of $71M fraud scheme—DOJ announces prison sentences

Pagination

    • First page « First
    • Previous page ‹ Previous
    • Page …58
    • Page 59
    • Page 60
    • Page 61
    • Current page 62
    • Page 63
    • Page 64
    • Page 65
    • Page 66 …
    • Next page Next ›
    • Last page Last »
Subscribe
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme